+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain



Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain



Pain 149(1): 33-49



Nicotinic acetylcholine receptors (nAChRs) are longstanding targets for a next generation of pain therapeutics, but the nAChR subtypes that govern analgesia remain unknown. We tested a series of nicotinic agonists, including many molecules used or tried clinically, on a panel of cloned neuronal nAChRs for potency and selectivity using patch-clamp electrophysiology and a live cell-based fluorescence assay. Nonselective nicotinic agonists as well as compounds selective either for alpha4beta2 or for alpha7 nAChRs were then tested in the formalin and complete Freund's adjuvant models of pain. Nonselective nAChR agonists ABT-594 and varenicline were effective analgesics. By contrast, the selective alpha4beta2 agonist ispronicline and a novel alpha4beta2-selective potentiator did not appear to produce analgesia in either model. alpha7-selective agonists reduced the pain-related endpoint, but the effect could be ascribed to nonspecific reduction of movement rather than to analgesia. Neither selective nor nonselective alpha7 nicotinic agonists affected the release of pro-inflammatory cytokines in response to antigen challenge. Electrophysiological recordings from spinal cord slice showed a strong nicotine-induced increase in inhibitory synaptic transmission that was mediated partially by alpha4beta2 and only minimally by alpha7 subtypes. Taken with previous studies, the results suggest that agonism of alpha4beta2 nAChRs is necessary but not sufficient to produce analgesia, and that the spinal cord is a key site where the molecular action of nAChRs produces analgesia.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054961074

Download citation: RISBibTeXText

PMID: 20167427

DOI: 10.1016/j.pain.2010.01.007


Related references

Antinociceptive effect of subtype selective nicotinic acetylcholine receptor agonists in rat models of pain. Society for Neuroscience Abstracts 24(1-2): 332, 1998

Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain. Pain 86(1-2): 113-118, 2000

The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents. Life Sciences 62(17-18): 1601-1606, March 27, 1998

The selective nicotinic acetylcholine receptor Î 7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain. Neuropharmacology 56(1): 0-263, 2009

Pharmacological characterization of SIB-1553A, a novel, subtype-selective neuronal nicotinic acetylcholine receptor agonist. Society for Neuroscience Abstracts 23(1-2): 1200, 1997

Subtype-selective nicotinic acetylcholine receptor agonists can improve cognitive flexibility in an attentional set shifting task. Neuropharmacology 105: 106-113, 2016

Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies. Bioorganic & Medicinal Chemistry Letters 19(22): 6353-6357, 2010

Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test. Journal of Psychopharmacology 25(10): 1347-1356, 2012

Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists. Bioorganic & Medicinal Chemistry Letters 19(16): 4747-4751, 2009

Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP. European Journal of Pharmacology 671(1-3): 26-32, 2012

The regulation of hippocampal nicotinic acetylcholine receptors (nAChRs) after a protracted treatment with selective or nonselective nAChR agonists. Journal of Molecular Neuroscience 13(1-2): 31-45, 2000

PHARMACOLOGICAL CHARACTERISATION AND in vitro PHYSIOLOGICAL EFFECTS OF NEW alpha7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 137 5, 2002

Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats. Journal of Pharmacology and Experimental Therapeutics 355(2): 341-350, 2016

Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-nicotinic acetylcholine receptor-selective partial agonists. Journal of Medicinal Chemistry 53(19): 6973-6985, 2010

Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing. Neuropharmacology 49 Suppl 1: 206-218, 2005